{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:18:53Z","timestamp":1790399933922,"version":"4.1.0"},"reference-count":115,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T00:00:00Z","timestamp":1649289600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ejmech.2022.114354","type":"journal-article","created":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T02:39:19Z","timestamp":1649385559000},"page":"114354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Design, synthesis, and in\u00a0vitro and in\u00a0vivo characterization of new memantine analogs for Alzheimer's disease"],"prefix":"10.1016","volume":"236","author":[{"given":"Andreea L.","family":"Turcu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00falia","family":"Companys-Alemany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew B.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhilon S.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gri\u00f1\u00e1n-Ferr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Isabel","family":"Loza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Brea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc X.","family":"Sureda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G.","family":"Kurnikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon W.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merc\u00e8","family":"Pall\u00e0s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.114354_bib1","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1017\/S135561771700100X","article-title":"Alzheimer's disease: past, present, and future","volume":"23","author":"Bondi","year":"2017","journal-title":"J.\u00a0Int. Neuropsychol. Soc."},{"key":"10.1016\/j.ejmech.2022.114354_bib2","series-title":"Alzheimer's Disease International","year":"2019"},{"key":"10.1016\/j.ejmech.2022.114354_bib3","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1474-4422(18)30403-4","article-title":"Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejmech.2022.114354_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173554","article-title":"Alzheimer's disease: recent treatment strategies","volume":"887","author":"Vaz","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114354_bib5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer's disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2022.114354_bib6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0140-6736(21)01455-0","article-title":"USA FDA defends approval of Alzheimer's disease drug","volume":"398","author":"Jaffe","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2022.114354_bib7","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1212\/WNL.0000000000012453","article-title":"Clinical efficacy, drug safety and surrogate endpoints: has aducanumab met\u00a0all of its expectations?","volume":"97","author":"Hershey","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.ejmech.2022.114354_bib8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1212\/WNL.0000000000012451","article-title":"Aducanumab, amyloid lowering, and slowing of Alzheimer disease","volume":"97","author":"Salloway","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.ejmech.2022.114354_bib9","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1212\/WNL.0000000000012452","article-title":"Prescribing aducanumab in the face of meager efficacy and real risks","volume":"97","author":"Knopman","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.ejmech.2022.114354_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108352","article-title":"Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease","volume":"190","author":"Marucci","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2022.114354_bib11","article-title":"Metrifonate for Alzheimer's disease","volume":"2","author":"L\u00f3pez-Arrieta","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejmech.2022.114354_bib12","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1517\/13543784.16.7.1087","volume":"16","author":"Phenserine","year":"2007","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.ejmech.2022.114354_bib13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/B978-0-12-386467-3.00010-8","article-title":"A\u00a0novel anti-Alzheimer's disease drug, ladostigil neuroprotective, multimodal brain-selective monoamine oxidase and cholinesterase inhibitor","volume":"100","author":"Weinreb","year":"2011","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.ejmech.2022.114354_bib14","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3390\/ijms20041000","article-title":"Discovery of novel ncetylcholinesterase inhibitors as potential candidates for the treatment of Alzheimer's Disease","volume":"20","author":"Son","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2022.114354_bib15","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2174\/1568026619666190128125912","article-title":"Target enzyme in Alzheimer's disease: acetylcholinesterase inhibitors","volume":"19","author":"Saxena","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114354_bib16","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/13543776.2021.1874344","article-title":"Acetylcholinesterase inhibitors for the treatment of Alzheimer's disease \u2013 a patent review (2016\u2013present)","volume":"31","author":"Bortolami","year":"2021","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2022.114354_bib17","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3233\/JAD-170424","article-title":"Memantine for Alzheimer's disease: an updated systematic review and meta-analysis","volume":"60","author":"Kishi","year":"2017","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.ejmech.2022.114354_bib18","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1080\/14740338.2018.1524870","article-title":"The efficacy and safety of memantine for the treatment of Alzheimer's disease","volume":"17","author":"Matsunaga","year":"2018","journal-title":"Expet Opin. Drug Saf."},{"key":"10.1016\/j.ejmech.2022.114354_bib19","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.neuropharm.2007.07.013","article-title":"Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse","volume":"53","author":"Parsons","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2022.114354_bib20","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1476-5381.2012.02057.x","article-title":"Alzheimer's disease, \u03b2-amyloid, glutamate, NMDA receptors and memantine\u2014searching for the connections","volume":"167","author":"Danysz","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114354_bib21","doi-asserted-by":"crossref","first-page":"11246","DOI":"10.1523\/JNEUROSCI.2488-10.2010","article-title":"Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses","volume":"30","author":"Xia","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ejmech.2022.114354_bib22","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.neuropharm.2009.01.012","article-title":"Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-D-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1\/GluN2A) receptors","volume":"56","author":"Gilling","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2022.114354_bib23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1586\/ecp.09.7","article-title":"A\u00a0moderate-affinity NMDA receptor channel blocker: new prospects and indications","volume":"2","author":"Neramexane","year":"2009","journal-title":"Expet Rev. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114354_bib24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2174\/156720506777632808","article-title":"The pharmacology of aminoadamantane nitrates","volume":"3","author":"Wang","year":"2006","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ejmech.2022.114354_bib25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejps.2013.02.013","article-title":"Memantine-sulfur containing antioxidant conjugates as potential prodrugs to improve the treatment of Alzheimer's disease","volume":"49","author":"Wang","year":"2013","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2022.114354_bib26","doi-asserted-by":"crossref","first-page":"14781","DOI":"10.1038\/srep14781","article-title":"Pharmacologically targeted NMDA receptor antagonism by nitromemantine for cerebrovascular disease","volume":"5","author":"Takahashi","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2022.114354_bib27","doi-asserted-by":"crossref","first-page":"45627","DOI":"10.1038\/srep45627","article-title":"Novel conjugates of aminoadamantanes with carbazole derivatives as potential multitarget agents for AD treatment","volume":"30","author":"Bachurin","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2022.114354_bib28","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1021\/acschemneuro.8b00154","article-title":"Pharmacological and electrophysiological characterization of novel NMDA receptor antagonists","volume":"9","author":"Leiva","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2022.114354_bib29","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.bmc.2017.12.021","article-title":"Design, synthesis, and evaluation of polyamine-memantine hybrids as NMDA channel blockers","volume":"26","author":"Kumamoto","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114354_bib30","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1038\/s41598-019-40925-8","article-title":"Memantine prodrug as a new agent for Alzheimer's disease","volume":"9","author":"Sestito","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2022.114354_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13371","article-title":"Therapeutic efficacy of novel memantine nitrate MN-08 in animal models of Alzheimer's disease","volume":"20","author":"Wu","year":"2021","journal-title":"Aging Cell"},{"key":"10.1016\/j.ejmech.2022.114354_bib32","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/ijnp\/pyaa075","article-title":"Anti-amnesic and neuroprotective effects of fluoroethylnormemantine in a pharmacological mouse model of Alzheimer's disease","volume":"24","author":"Couly","year":"2021","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejmech.2022.114354_bib35","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/JCP.0000000000001035","article-title":"Characterization of the safety and pharmacokinetic profile of d-methadone, a novel N-Methyl-D-Aspartate receptor antagonist in healthy, opioid-naive subjects: results of two phase 1 studies","volume":"39","author":"Bernstein","year":"2019","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"key":"10.1016\/j.ejmech.2022.114354_bib37","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1111\/j.1471-4159.2007.04925.x","article-title":"Comparison of the pharmacological properties of GK11 and MK801, two NMDA receptor antagonists: towards an explanation for the lack of intrinsic neurotoxicity of GK11","volume":"103","author":"Vandame","year":"2007","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ejmech.2022.114354_bib40","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nm.4050","article-title":"Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants","volume":"22","author":"Duman","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2022.114354_bib42","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bmc.2009.11.017","article-title":"New oxapolycyclic cage amines with NMDA receptor antagonist and trypanocidal activities","volume":"18","author":"Duque","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114354_bib43","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.bmc.2011.11.050","article-title":"Synthesis of benzopolycyclic cage amines: NMDA receptor antagonist, trypanocidal and antiviral activities","volume":"20","author":"Torres","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114354_bib44","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1016\/j.bmc.2014.03.025","article-title":"Novel benzopolycyclic amines with NMDA receptor antagonist activity","volume":"22","author":"Valverde","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114354_bib45","doi-asserted-by":"crossref","first-page":"491","DOI":"10.4155\/fmc-2016-0032","article-title":"Deuterium medicinal chemistry comes of age","volume":"8","author":"Tung","year":"2016","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114354_bib46","doi-asserted-by":"crossref","first-page":"5276","DOI":"10.1021\/acs.jmedchem.8b01808","article-title":"Applications of deuterium in medicinal chemistry","volume":"62","author":"Pirali","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114354_bib47","first-page":"519","article-title":"A\u00a0decade of deuteration in medicinal chemistry","volume":"50","author":"Liu","year":"2017","journal-title":"Annu. Rep. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114354_bib48","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.4155\/fmc-2019-0183","article-title":"A\u00a0primer of deuterium in drug design","volume":"11","author":"Cargnin","year":"2019","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114354_bib49","doi-asserted-by":"crossref","first-page":"9925","DOI":"10.1016\/j.bmc.2008.10.028","article-title":"Synthesis and pharmacological evaluation of several ring-contracted amantadine analogs","volume":"16","author":"Camps","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114354_bib50","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1071\/CH9832465","article-title":"The intramolecular cyclization of unsaturated benzo derivatives of Bicyclo[3.3.2]decane","volume":"36","author":"Bishop","year":"1983","journal-title":"Aust. J. Chem."},{"key":"10.1016\/j.ejmech.2022.114354_bib51","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/S0040-4039(01)81048-0","article-title":"Ritter reactions. II. Reductive deamidation of N-bridgehead amides","volume":"28","author":"Bishop","year":"1987","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2022.114354_bib52","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.1021\/ol102685u","article-title":"NHC-Catalyzed spiro bis-indane formation via domino Stetter-Aldol-Michael and Stetter-Aldol-Aldol reactions","volume":"12","author":"S\u00e1nchez-Larios","year":"2010","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2022.114354_bib53","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1039\/p19900002929","article-title":"Vinyl azides in heterocyclic synthesis. Part 10. Synthesis of the isoindolobenzazepine alkaloid lennoxamine","volume":"1","author":"Moody","year":"1990","journal-title":"J.\u00a0Chem. Soc. Perkin Trans."},{"key":"10.1016\/j.ejmech.2022.114354_bib54","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1055\/s-1994-25632","article-title":"Oxidation of aromatic 1,2-dimethanols by activated dimethyl sulfoxide. O","volume":"10","author":"Farooq","year":"1994","journal-title":"Synthesis"},{"key":"10.1016\/j.ejmech.2022.114354_bib55","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1021\/jo01266a063","article-title":"Directional effects of substituents in the ozonolysis of naphthalenes. Synthesis of o-phthalaldehydes","volume":"33","author":"Pappas","year":"1968","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2022.114354_bib56","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1016\/S0040-4020(01)80896-6","article-title":"General approach for the synthesis of polyquinenes via the Weiss reaction","volume":"47","author":"Gupta","year":"1991","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2022.114354_bib57","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0014-4886(02)00029-8","article-title":"Neuroprotective effects of (+\/-)-huprine Y on in\u00a0vitro and in\u00a0vivo models of excitoxicity damage","volume":"180","author":"Canudas","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejmech.2022.114354_bib58","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41586-018-0039-9","article-title":"Mechanism of NMDA receptor channel block by MK-801 and memantine","volume":"556","author":"Song","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2022.114354_bib59","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1021\/cn300180a","article-title":"Key binding interactions for memantine in the NMDA receptor","volume":"4","author":"Limapichat","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2022.114354_bib60","first-page":"469","article-title":"AMPAR interacting protein CPT1C enhances surface expression of GluA1-containing receptors","volume":"8","author":"Gratac\u00f2s-Batlle","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejmech.2022.114354_bib61","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1476-5381.1996.tb15971.x","article-title":"Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells","volume":"119","author":"Bresink","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114354_bib62","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1460-9568.1996.tb01228.x","article-title":"Comparative patch-clamp studies with freshly dissociated rat hippocampal and striatal neurons on the NMDA receptor antagonistic effects of amantadine and memantine","volume":"8","author":"Parsons","year":"1996","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejmech.2022.114354_bib63","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1152\/jn.1997.77.1.309","article-title":"Trapping channel block of NMDA-activated responses by amantadine and memantine","volume":"77","author":"Blanpied","year":"1997","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.ejmech.2022.114354_bib64","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1523\/JNEUROSCI.4262-04.2005","article-title":"Amantadine inhibits NMDA receptors by accelerating channel closure during channel block","volume":"25","author":"Blanpied","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ejmech.2022.114354_bib65","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.neuropharm.2007.07.013","article-title":"Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse","volume":"53","author":"Parsons","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2022.114354_bib66","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-1-59745-529-9_2","article-title":"Memantine as an example of a fast, voltage-dependent, open channel N-methyl-D-aspartate receptor blocker","volume":"403","author":"Parsons","year":"2007","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejmech.2022.114354_bib67","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1523\/JNEUROSCI.3703-08.2009","article-title":"Mg2+ imparts NMDA receptor subtype selectivity to the Alzheimer's drug memantine","volume":"29","author":"Kotermanski","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ejmech.2022.114354_bib68","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.neuropharm.2010.10.008","article-title":"Quantification of the Mg2+-induced potency shift of amantadine and memantine voltage-dependent block in human recombinant GluN1\/GluN2A NMDARs","volume":"60","author":"Otton","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2022.114354_bib69","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1523\/JNEUROSCI.16-02-00631.1996","article-title":"Neuronal activity differentially regulates NMDA receptor subunit expression in cerebellar granule cells","volume":"16","author":"Vallano","year":"1996","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ejmech.2022.114354_bib70","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/14734220510007996","article-title":"Modulation of NMDA receptors in the cerebellum. 1. Properties of the NMDA receptor that modulate its function","volume":"4","author":"Llansola","year":"2005","journal-title":"Cerebellum"},{"key":"10.1016\/j.ejmech.2022.114354_bib71","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.1523\/JNEUROSCI.20-16-05899.2000","article-title":"Developmental profile of the changing properties of NMDA receptors at cerebellar mossy fiber-granule cell synapses","volume":"20","author":"Cathala","year":"2000","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ejmech.2022.114354_bib72","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0896-6273(92)90120-3","article-title":"Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit","volume":"8","author":"Burnashev","year":"1992","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2022.114354_bib73","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/358673a0","article-title":"Identification by mutagenesis of a Mg(2+)-block site of the NMDA receptor channel","volume":"358","author":"Mori","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2022.114354_bib74","first-page":"533","article-title":"Channel blockers acting at N-methyl-d-aspartate receptors: differential effects of mutations in the vestibule and ion channel pore","volume":"61","author":"Kashiwagi","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114354_bib75","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1124\/jpet.105.085142","article-title":"Pharmacological implications of two distinct mechanisms of interaction of memantine with N-methyl-D-aspartate-gated channels","volume":"314","author":"Chen","year":"2005","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2022.114354_bib76","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1113\/jphysiol.1991.sp018396","article-title":"Actions of ketamine, phencyclidine and MK-801 on NMDA receptor currents in cultured mouse hippocampal neurones","volume":"432","author":"MacDonald","year":"1991","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.ejmech.2022.114354_bib77","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/j.neuropharm.2011.12.029","article-title":"Influence of external magnesium ions on the NMDA receptor channel block by different types of organic cations","volume":"62","author":"Nikolaev","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2022.114354_bib78","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.neuropharm.2018.05.017","article-title":"Effects of Mg2+ on recovery of NMDA receptors from inhibition by memantine and ketamine reveal properties of a second site","volume":"137","author":"Glasgow","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2022.114354_bib79","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1085\/jgp.61.6.687","article-title":"Ionic blockage of sodium channels in nerve","volume":"61","author":"Woodhull","year":"1973","journal-title":"J.\u00a0Gen. Physiol."},{"key":"10.1016\/j.ejmech.2022.114354_bib80","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0028-3908(99)00019-2","article-title":"Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data","volume":"38","author":"Parsons","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2022.114354_bib81","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.neuropharm.2009.01.012","article-title":"Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-D-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1\/GluN2A) receptors","volume":"56","author":"Gilling","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2022.114354_bib82","unstructured":"Oral Administration of IIc (5 Mg\/kg) to Mice Led to its Fast Absorption from the Gastrointestinal Tract, Reaching a Maximum Plasma Concentration (Cmax) of 1.12 \u00b1 0.76 \u039cM after 45 Min. Interestingly, a Much Higher Concentration of UB-ALT-EV Was Found in Brain as Compared to Plasma, Indicating a Fast and Very High BBB Penetration. A Cmax of 17.10 \u00b1 6.06 \u03bcM was Determined in Brain Which Was Reached after about 1 H (Tmax\u00a0= 56 Min). Thus, the Cmax in Brain Was 15-fold Higher than that in Plasma. A Brain\/plasma Ratio of 32 Was Observed after 1 H at Cmax (Brain). Companys-Alemany, J.; Turcu, A. L.; Schneider, M.; M\u00fcller, C. E.; V\u00e1zquez, S.; Gri\u00f1\u00e1n-Ferr\u00e9, C.; Pall\u00e0s, M. NMDA Receptor Antagonists Reduce Amyloid-\u03b2 Deposition by Modulating Calpain-1 Signaling and Autophagy, Rescuing Cognitive Impairment in 5XFAD Mice, Unpublished Results."},{"key":"10.1016\/j.ejmech.2022.114354_bib83","first-page":"1","article-title":"Isoquinoline alkaloids reduce beta-amyloid peptide toxicity in Caenorhabditis elegans","author":"de Almeida","year":"2020","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.ejmech.2022.114354_bib84","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.brainresbull.2021.07.007","article-title":"Caenorhabditis elegans as a model for studies on quinolinic acid-induced NMDAR-dependent glutamatergic disorders","volume":"175","author":"Limana da Silveira","year":"2021","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejmech.2022.114354_bib85","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.cub.2008.05.051","article-title":"Memory in Caenorhabditis elegans is mediated by NMDA-type ionotropic glutamate receptors","volume":"18","author":"Kano","year":"2008","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ejmech.2022.114354_bib86","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000072159","article-title":"Ionotropic glutamate receptors in Caenorhabditis elegans","volume":"12","author":"Brockie","year":"2003","journal-title":"Neurosignals"},{"key":"10.1016\/j.ejmech.2022.114354_bib87","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.3390\/ijms22126298","article-title":"Amyloid beta-mediated changes in synaptic function and spine number of neocortical neurons depend on NMDA receptors","volume":"22","author":"Back","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2022.114354_bib88","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hipo.22267","article-title":"Onset of hippocampus-dependent memory impairments in 5XFAD transgenic mouse model of Alzheimer's disease","volume":"24","author":"Girard","year":"2014","journal-title":"Hippocampus"},{"key":"10.1016\/j.ejmech.2022.114354_bib89","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.pbb.2016.03.002","article-title":"Cognitive benefits of memantine in Alzheimer's 5XFAD model mice decline during advanced disease stages","volume":"144","author":"Devi","year":"2016","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejmech.2022.114354_bib90","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1111\/jphp.13165","article-title":"Effects of the drug combination memantine and melatonin on impaired memory and brain neuronal deficits in an amyloid-predominant mouse model of Alzheimer's disease","volume":"71","author":"J\u00fcrgenson","year":"2019","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114354_bib91","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13065-015-0143-y","article-title":"Using C.\u00a0elegans to discover therapeutic compounds for ageing-associated neurodegenerative diseases","volume":"9","author":"Chen","year":"2015","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.ejmech.2022.114354_bib92","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.3390\/nu13072411","article-title":"Synergistic neuroprotective effects of a natural product Mixture against AD hallmarks and cognitive decline in Caenorhabditis elegans and an SAMP8 mice model","volume":"13","author":"Gri\u00f1\u00e1n-Ferr\u00e9","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.ejmech.2022.114354_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.713726","article-title":"Comprehensive evaluation of the 5XFAD mouse model for preclinical testing applications: a MODEL-AD study","volume":"13","author":"Oblak","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ejmech.2022.114354_bib94","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrn2911","article-title":"Synaptic versus extrasynaptic NMDA receptor signaling: implications for neurodegenerative disorders","volume":"11","author":"Hardingham","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejmech.2022.114354_bib95","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1523\/JNEUROSCI.0116-07.2007","article-title":"NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in\u00a0vitro and in\u00a0vivo","volume":"27","author":"Liu","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ejmech.2022.114354_bib96","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.pneurobio.2011.02.002","article-title":"Post-synaptic scaffolding protein interactions with glutamate receptors in synaptic dysfunction and Alzheimer's disease","volume":"93","author":"Proctor","year":"2011","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.ejmech.2022.114354_bib97","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1007\/s11064-012-0726-0","article-title":"NR2B-containing NMDA receptors expression and their relationship to apoptosis in hippocampus of Alzheimer's disease-like rats","volume":"37","author":"Liu","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejmech.2022.114354_bib98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2015.01.041","article-title":"Memantine selectively blocks extrasynaptic NMDA receptors in rat substantia nigra dopamine neurons","volume":"1603","author":"Wu","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.ejmech.2022.114354_bib99","first-page":"1041","article-title":"Role of glutamate and NMDA receptors in Alzheimer's Disease","volume":"57","author":"Wang","year":"2017","journal-title":"J.\u00a0Alz. Dis."},{"key":"10.1016\/j.ejmech.2022.114354_bib100","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.bbadis.2018.03.019","article-title":"Age-related NMDA signaling alterations in SOD2 deficient mice","volume":"1864","author":"Carvajal","year":"2018","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.ejmech.2022.114354_bib101","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.nbd.2012.10.024","article-title":"Enhanced NMDA receptor tyrosine phosphorylation and increased brain injury following neonatal hypoxia-ischemia in mice with neuronal Fyn overexpression","volume":"51","author":"Knox","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejmech.2022.114354_bib102","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.neuron.2005.08.016","article-title":"The synaptic localization of NR2B-containing NMDA receptors is controlled by interactions with PDZ proteins and AP-2","volume":"47","author":"Prybylowski","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2022.114354_bib103","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s12031-017-0919-8","article-title":"The involvement of NR2B and tau protein in MG132-induced CREB dephosphorylation","volume":"62","author":"Xie","year":"2017","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.ejmech.2022.114354_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118020","article-title":"The role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease","volume":"257","author":"Amidfar","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2022.114354_bib105","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jalz.2019.07.017","article-title":"Amyloid pathology-produced unexpected modifications of calcium homeostasis in hippocampal subicular dendrites","volume":"16","author":"Angulo","year":"2020","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.ejmech.2022.114354_bib106","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2022.114354_bib107","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/jcc.20945","article-title":"CHARMM-GUI: a web-based graphical user interface for CHARMM","volume":"29","author":"Jo","year":"2008","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2022.114354_bib108","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/jcc.23702","article-title":"CHARMM-GUI Membrane Builder toward realistic biological membrane simulations","volume":"35","author":"Wu","year":"2014","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2022.114354_bib109","series-title":"AMBER 2018","author":"Case","year":"2018"},{"key":"10.1016\/j.ejmech.2022.114354_bib110","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","article-title":"ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB","volume":"11","author":"Maier","year":"2015","journal-title":"J.\u00a0Chem. Theor. Comput."},{"key":"10.1016\/j.ejmech.2022.114354_bib111","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1021\/ct4010307","article-title":"Lipid14: the Amber lipid force field","volume":"10","author":"Dickson","year":"2014","journal-title":"J.\u00a0Chem. Theor. Comput."},{"key":"10.1016\/j.ejmech.2022.114354_bib112","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2022.114354_bib113","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0021-9991(77)90098-5","article-title":"Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes","volume":"23","author":"Ryckaert","year":"1977","journal-title":"J.\u00a0Comp. Phys."},{"key":"10.1016\/j.ejmech.2022.114354_bib114","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N-log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J.\u00a0Chem. Phys."},{"key":"10.1016\/j.ejmech.2022.114354_bib115","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J.\u00a0Mol. Graph."},{"key":"10.1016\/j.ejmech.2022.114354_bib116","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe","year":"2013","journal-title":"J.\u00a0Chem. Theor. Comput."},{"key":"10.1016\/j.ejmech.2022.114354_bib117","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-1-4939-1096-0_2","article-title":"Whole-cell patch-clamp analysis of recombinant NMDA receptor pharmacology using brief glutamate applications","volume":"1183","author":"Glasgow","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejmech.2022.114354_bib118","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.1113\/JP278168","article-title":"Functional and pharmacological properties of triheteromeric GluN1\/2B\/2D NMDA receptors","volume":"597","author":"Yi","year":"2019","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.ejmech.2022.114354_bib119","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1085\/jgp.61.6.687","article-title":"Ionic blockage of sodium channels in nerve","volume":"61","author":"Woodhull","year":"1973","journal-title":"J.\u00a0Gen. Physiol."},{"key":"10.1016\/j.ejmech.2022.114354_bib120","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/2167","article-title":"Binding sites for permeant ions in the channel of NMDA receptors and their effects on channel block","volume":"1","author":"Antonov","year":"1998","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejmech.2022.114354_bib121","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood-brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422002562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422002562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:43:57Z","timestamp":1759329837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422002562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":115,"alternative-id":["S0223523422002562"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114354","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and in\u00a0vitro and in\u00a0vivo characterization of new memantine analogs for Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114354","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114354"}}